The 30-Day Metric in Acute Heart Failure Revisited: Data from in-Hf Outcome, an Italian Nationwide Cardiology Registry
- 27 May 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 17 (10) , 1032-1041
Abstract
Aims Unplanned readmissions early after a discharge from acute heart failure hospitalization are common and have become a reimbursement benchmark and marker of hospital quality. However, the competing risk of short‐term post‐discharge mortality is substantial. Methods and results Using data from the prospective, nationwide Registry IN‐HF Outcome, we analysed the incidence and predictors of 30‐day mortality or readmissions and associated days‐alive‐out‐of‐hospital (DAOH) in 1520 patients discharged alive after admission for acute heart failure. Within 30 days after discharge, 94 patients (6.2%) were readmitted (91% for cardiovascular causes; 60% recurrent heart failure) and 42 (2.8%) died, 10 of which occurred during readmission. Overall, 126 patients (8.3%) met the combined endpoint. By multivariable logistic regression, worsening chronic heart failure as clinical presentation [odds ratio (OR) 1.83, 95% confidence interval (CI) 1.21–2.77, P = 0.005), inotropes during admission (OR 2.19, 95% CI 1.40–3.43, P = 0.0006), length of stay (OR 1.02, 95% CI 1.01–1.04, P = 0.002) and renin–angiotensin system inhibitors at discharge (OR 0.52, 95%CI 0.35–0.77, P = 0.001) independently predicted 30‐day all‐cause mortality and/or readmission (c‐statistic = 0.695). Per cent 30‐day DAOH was lower in patients with in‐hospital inotrope use, no renin–angiotensin system inhibitors prescription at discharge, New York Heart Association III–IV class at discharge, and correlated inversely with length of stay and age. Conclusion A clinical and biohumoral profile consistent with chronic advanced heart failure and end‐organ damage identifies acute heart failure patients discharged home from cardiology units, who are at highest risk of early death and/or readmission. These findings have practical implications for tailoring specific follow‐up.Keywords
Funding Information
- Novartis
- Abbott
- Medtronic
This publication has 31 references indexed in Scilit:
- The Global Health and Economic Burden of Hospitalizations for Heart FailureJACC, 2014
- Validated, Electronic Health Record Deployable Prediction Models for Assessing Patient Risk of 30-Day Rehospitalization and Mortality in Older Heart Failure PatientsJACC: Heart Failure, 2013
- Relationship Between Hospital Readmission and Mortality Rates for Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, or PneumoniaJAMA, 2013
- Rehospitalization for Heart FailureJACC, 2013
- Acute Heart Failure Patient Profiles, Management and In-Hospital Outcome: Results of the Italian Registry on Heart Failure OutcomeEuropean Journal of Heart Failure, 2012
- Predicting the risk of unplanned readmission or death within 30 days of discharge after a heart failure hospitalizationAmerican Heart Journal, 2012
- Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programAmerican Heart Journal, 2011
- Incremental Value of Clinical Data Beyond Claims Data in Predicting 30-Day Outcomes After Heart Failure HospitalizationCirculation: Cardiovascular Quality and Outcomes, 2011
- End Points for Clinical Trials in Acute Heart Failure SyndromesJACC, 2009
- Miscellanea. Small-sample degrees of freedom with multiple imputationBiometrika, 1999